TriangleCIML-NK Cells (NCT05580601)
CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
Lo que dice el vídeo
Lee la transcripción
This trial is for acute myeloid leukemia that has returned or has not responded to treatment, in people 2 and older.
The idea: use natural killer cells from a donor. NK cells are collected from a related, half-matched donor, treated with cytokines to become memory-like cells, and infused into the patient. Eligibility requires at least five percent blasts in the bone marrow.
This phase 1 and 2 study first asks whether the infusion is feasible and safe. At Cincinnati Children's Hospital in Ohio, Zahra Hudda leads it.
Public record; not medical advice.
¿Ya estás en un ensayo?
Se convierte en un proyecto que hay que manejar: citas, estudios de imagen, análisis, efectos secundarios y papeleo. Triangle lo mantiene organizado en un solo lugar, para ti o para quien te ayuda.
Organizar mi ensayoPrueba gratuita de 7 días, después $9 al mes. Cancela cuando quieras.
Cómo funcionan estos ensayos: qué es de verdad la fase 1 · preguntas frecuentes No es evidencia clínica.